Literature DB >> 16399849

Halothane directly modifies Na+ and K+ channel activities in cultured human alveolar epithelial cells.

Antoine Roch1, Vadim Shlyonsky, Arnaud Goolaerts, Frédérique Mies, Sarah Sariban-Sohraby.   

Abstract

During inhalational anesthesia, halogenated gases are in direct contact with the alveolar epithelium, in which they may affect transepithelial ion and fluid transport. The effects of halogenated gases in vivo on epithelial Na+ and K+ channels, which participate in alveolar liquid clearance, remain unclear. In the present study, the effects of halothane (1, 2, and 4% atm) on ion-channel function in cultured human alveolar cells were investigated using the patch-clamp technique. After exposure to 4% halothane, amiloride-sensitive whole-cell inward currents increased by 84+/-22%, whereas tetraethylammonium-sensitive outward currents decreased by 63+/-7%. These effects, which occurred within 30 s, remained for 30-min periods of exposure to the gas, were concentration-dependent, and were reversible upon washout. Pretreatment with amiloride prevented 90+/-7% of the increase in inward currents without change in outward currents, consistent with an activation of amiloride-sensitive epithelial sodium channels. Tetraethylammonium obliterated 90+/-9% of the effect of halothane on outward currents, without change in inward currents, indicating inhibition of Ca2+-activated K+ channels. These channels were identified in excised patches to be small-conductance Ca2+-activated K+ channels. These effects of halothane were not modified after the inhibition of cytosolic phospholipase A2 by aristolochic acid. Exposure of the cells to either trypsin or to low Na+ completely prevented the increase in amiloride-sensitive currents induced by halothane, suggesting a release of Na+ channels self-inhibition. Thus, halothane modifies differentially and independently Na+ and K+ permeabilities in human alveolar cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16399849     DOI: 10.1124/mol.105.021485

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

Review 1.  General anesthetics and molecular mechanisms of unconsciousness.

Authors:  Stuart A Forman; Victor A Chin
Journal:  Int Anesthesiol Clin       Date:  2008

2.  The guinea-pig tracheal potential difference as an in vivo model for the study of epithelial sodium channel function in the airways.

Authors:  K J Coote; H Atherton; A Young; R Sugar; R Burrows; N J Smith; J-M Schlaeppi; P J Groot-Kormelink; M Gosling; H Danahay
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

3.  8-(4-chlorophenylthio)-guanosine-3',5'-cyclic monophosphate-Na stimulates human alveolar fluid clearance by releasing external Na+ self-inhibition of epithelial Na+ channels.

Authors:  Dong-Yun Han; Hong-Guang Nie; Xue-Feng Su; Xue-Mei Shi; Deepa Bhattarai; Meimi Zhao; Run-Zhen Zhao; Katlin Landers; Hua Tang; Lin Zhang; Hong-Long Ji
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05-11       Impact factor: 6.914

4.  Cpt-cAMP activates human epithelial sodium channels via relieving self-inhibition.

Authors:  Raul Molina; Dong-Yun Han; Xue-Feng Su; Run-Zhen Zhao; Meimi Zhao; Gretta M Sharp; Yongchang Chang; Hong-Long Ji
Journal:  Biochim Biophys Acta       Date:  2011-03-17

5.  THIK-1 (K2P13.1) is a small-conductance background K(+) channel in rat trigeminal ganglion neurons.

Authors:  Dawon Kang; James O Hogan; Donghee Kim
Journal:  Pflugers Arch       Date:  2013-10-01       Impact factor: 3.657

6.  Aristolochic acid, a plant extract used in the treatment of pain and linked to Balkan endemic nephropathy, is a regulator of K2P channels.

Authors:  Emma L Veale; Alistair Mathie
Journal:  Br J Pharmacol       Date:  2016-04-05       Impact factor: 8.739

Review 7.  CPT-cGMP Is A New Ligand of Epithelial Sodium Channels.

Authors:  Hong-Long Ji; Hong-Guang Nie; Yongchang Chang; Qizhou Lian; Shan-Lu Liu
Journal:  Int J Biol Sci       Date:  2016-01-28       Impact factor: 6.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.